Skip to main content
. 2022 Dec 16;23(24):16022. doi: 10.3390/ijms232416022

Table 1.

Summary of recent studies regarding microRNAs in pediatric myocarditis patients.

Ref. Year Population Comparison miRNA Outcome Methodology
Yan et al. [38] 2021 48 VMC pediatric pts 40 HCs miR-146b ↑ miR-146b in VMC pts compared to HCs miRs in serum by qPCR
Xia et al. [39] 2020 30 VMC pediatric pts HCs miR-217
miR-543
↑ miR-217 and miR-543 in study groups compared to controls miRs in blood by qPCR
Goldberg et al. [40] 2018 8 VMC pediatric pts comparison of acute, subacute and resolution/chronic phase of VMC miR-21
miR-208a
↑ miR-208a in acute phase compared to other phases
↓ miR-21 in resolution/chronic phase compared to other phases
miRs in serum by qPCR
Zhang et al. [41] 2018 26 VMC pediatric pts 33 pediatric pts recovered from VMC miR-381 ↓ miR-381 in VMC pts compared to recovered pts miRs in serum by qPCR
Zhang et al. [42] 2017 36 VMC pediatric pts HCs miR-133b ↓ miR-133b in VMC pts miRs in blood by qPCR
Wang et al. [43] 2016 119 VMC pediatric pts 120 HCs miR-1
miR-146b
↓ miR-1 and ↑ miR-146b in VMC pts miRs in serum by qPCR

↑—increased, ↓—decreased, HCs—healthy controls, miR/miRNA—microRNA, pts—patients, qPCR—quantitative polymerase chain reaction, ref.—reference, RNA—ribonucleic acid, VMC—viral myocarditis.